We also observed the poor prognostic value of TRIM28 in brain cancer, prostate cancer, blood cancer and renal cell carcinoma (Figure 5H, 5J–5L) and its good prognostic value in ovarian cancer (Figure 5I). This evidence concerns the gene TRIM28 and prostate carcinoma.